BMI OrganBank CEO Carrie DiMarzio Presents at the The Regenerative Manufacturing Innovation Consortium (RegMIC)

  • December 7th, 2022
  • Company & MilestonesResearch & Discovery

BMI OrganBankTM was proud to present at The Regenerative Manufacturing Innovation Consortium (RegMIC) meeting with industry partners where WFIRM Director Anthony Atala, MD, gave an opening welcome.

This meeting is all about sharing information and updates to advance regenerative medicine programs and technologies to address clinical needs in patients.  In addition, BMI OrganBank and fellow members of ReMDO’s RegeneratOR Test Bed opened up their labs for a tour of their groundbreaking endeavors.

Categories

Keeping more paths to transplant open.

PLATFORM & TECHNOLOGY

  • Platform Overview
  • Clinical Workflow
  • The Science
  • System Components

RESEARCH SERVICES

  • Ex-Vivo Institute
  • OrganBank Lab

CLINICAL EVIDENCE

  • Publications
  • Preclinical Validation
  • Data & Outcomes
  • Scientific Posters & Presentations

ABOUT

  • Our Story
  • Leadership
  • Consortium
  • Careers
  • Contact

NEWS & INSIGHTS

  • Company News
  • Featured Content
  • Resource Library
  • Newsletter

 

BMI OrganBank®
Wake Forest Institute of Regenerative Medicine
391 Technology Way | Winston-Salem, NC 27101 | USA

© 2026 BMI OrganBank. All rights reserved.
Privacy Policy Terms & Conditions

Blood-free perfusate

Proprietary acellular perfusate designed to support metabolically active preservation—enabling oxygen delivery, nutrient support, and management of oxidative stress without the need for donor-matched blood.

Real-time visibility across the journey

Tracks organ status and location during preservation and transport, supporting coordination and assessment across teams.

Portable perfusion. Continuous preservation.

Automated, portable device designed to maintain kidneys in a metabolically active state during preservation and transport.
Operates at room temperature without donor-matched blood.